Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elaine Blowers"'
Autor:
Elaine Blowers, Fiona C Thistlethwaite, Michelle Davies, Susan M Neeson, Kim Linton, Evelyn Dolan
Publikováno v:
Annals of Oncology. 29:viii695-viii696
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::775b83d88eb3dd48aa3b85fb20e57d4f
https://doi.org/10.1093/annonc/mdy277.003
https://doi.org/10.1093/annonc/mdy277.003
Autor:
Elaine Blowers, Sharon Foy
Publikováno v:
Practice Nursing. 20:282-286
Elaine Blowers and Sharon Foy outline the current treatments for breast cancer and the potential side effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8165d0308b69d6c8446fc4e6004b7cc3
https://doi.org/10.12968/pnur.2009.20.6.42553
https://doi.org/10.12968/pnur.2009.20.6.42553
Autor:
Elaine Blowers, Sharon Foy
Publikováno v:
Practice Nursing. 20:276-281
Sharon Foy and Elaine Blowers discuss the importance of recognizing the signs and symptoms of early and secondary breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ee326e253023d257eb2876acdf5d57b
https://doi.org/10.12968/pnur.2009.20.6.42552
https://doi.org/10.12968/pnur.2009.20.6.42552
Autor:
Kate Hall, Elaine Blowers
Publikováno v:
British Journal of Nursing. 18:424-428
Bevacizumab (Avastin®) is an anti-angiogenic agent recently approved for the treatment of metastatic breast cancer in combination with paclitaxel. It is important that nurses are familiar with the side-effects associated with this agent – several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1baa69d27eb4e4e068a759a0ffedd055
https://doi.org/10.12968/bjon.2009.18.7.41657
https://doi.org/10.12968/bjon.2009.18.7.41657
Autor:
Elaine Blowers, Kate Hall
Publikováno v:
British Journal of Nursing. 18:351-358
The anti-angiogenic agent bevacizumab (Avastin®) has received regulatory approval for the treatment of metastatic breast cancer (MBC) in combination with the taxane chemotherapy agent paclitaxel. A range of side-effects associated with this agent ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4aef3784881498434e4d0e09bdc880
https://doi.org/10.12968/bjon.2009.18.6.40767
https://doi.org/10.12968/bjon.2009.18.6.40767